SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Unicharm Corporation (UNICY) trades at a trailing P/E of 0.2, forward P/E of 0.1. Trailing earnings yield is 625.00%, forward earnings yield 769.23%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (625.00%).
- Forward P/E 0.1 (down from trailing 0.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 625.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 769.23% as earnings recover.
Overall SharesGrow Score: 80/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UNICY
Valuation Multiples
P/E (TTM)0.2
Forward P/E0.1
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$18.82
Forward EPS (Est.)$23.30
Book Value / Share$0.00
Revenue / Share$283.47
FCF / Share$0.00
Yields & Fair Value
Earnings Yield625.00%
Forward Earnings Yield769.23%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.87 |
$710.97B |
$44.13B |
6.2% |
| 2017 |
$3.47 |
$641.65B |
$52.77B |
8.2% |
| 2018 |
$4.05 |
$688.29B |
$61.35B |
8.9% |
| 2019 |
$15.40 |
$714.23B |
$46.12B |
6.5% |
| 2020 |
$17.49 |
$727.48B |
$52.34B |
7.2% |
| 2021 |
$24.34 |
$782.72B |
$72.75B |
9.3% |
| 2022 |
$22.72 |
$898.02B |
$67.61B |
7.5% |
| 2023 |
$29.08 |
$941.79B |
$86.05B |
9.1% |
| 2024 |
$23.05 |
$988.98B |
$81.84B |
8.3% |
| 2025 |
$18.82 |
$991.09B |
$68.37B |
6.9% |
